Skip to content

Alamar Biosciences

US · ALMR #2657 by market cap Listed 2026
26.48 -2.20 -7.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

Momentum strategy signal
Hold
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 2 analysts

Buy
Avg price target 36.00 +36.0%
Price target rangecurrent 26.48
Low36.00
Avg36.00
High36.00
Buy 50% Hold 50% Sell 0%
Recent ratings (13)
DateFirmAnalystRatingTarget
2026-11-04 TD Cowen -- Buy 36.00
2026-11-04 BofA Securities -- Hold --
2026-08-11 Stifel -- Buy 32.00
2026-08-10 BofA Securities -- Hold 31.00
2026-08-10 J.P. Morgan -- Buy 35.00
2026-07-21 J.P. Morgan -- Buy 32.00
2026-07-15 TD Cowen -- Buy 34.00
2026-06-09 Stifel -- Buy 28.00
2026-05-12 TD Cowen -- Buy 30.00
2026-05-12 BofA Securities -- Hold 27.00
2026-05-12 Stifel -- Buy 28.00
2026-05-12 Leerink Partners -- Buy 35.00
2026-05-12 J.P. Morgan -- Buy 30.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionActual move
2026/Q3 2026-11-03 After close -9.36%
2026/Q2 2026-08-10 After close +30.65%
2026/Q1 2026-05-08 -- +1.27%

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Alamar Biosciences discussion 0 comments

Add a comment